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Transcriptional response to exercise in type 2 diabetes 
Exercise induction of key transcriptional regulators of metabolic 
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Context: Type 2 diabetes (T2D) is characterized by insulin resistance in skeletal muscle. 
Regular exercise improves insulin sensitivity, mitochondrial function and energy metabolism. 
Thus, an impaired response to exercise may contribute to insulin resistance.  
Objective: We hypothesized that key transcriptional regulators of metabolic adaptation to 
exercise show an attenuated response in skeletal muscle in T2D.  
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Patients and Design: Skeletal muscle biopsies were obtained from 13 patients with T2D and 
14 age and weight-matched controls before, immediately after 1-h acute exercise (70% 
VO2max), and 3-h into recovery to examine mRNA expression of key transcription factors and 
downstream targets and activity of key upstream kinases underlying the metabolic adaptation 
to exercise.  
Results: Acute exercise increased gene expression of the nuclear hormone receptor 4A 
(NR4A) subfamily (~4-36-fold) and other key transcription factors including ATF3, EGR1, 
JUNB, SIK1, PPARA and PPARG (~1.5-12-fold), but with no differences between groups. 
The expression of NR4A1 (~8-fold) and NR4A3 (~75-fold) was further increased 3-h into 
recovery, whereas most muscle transcripts sustained elevated or returned to basal levels, 
again with no differences between groups. Muscle expression of HKII and SLC2A4, and 
HKII protein content were reduced in patients with T2D. The phosphorylation of p38 MAPK, 
Erk1/2, CaMKII and CREB was equally increased in response to exercise and/or recovery in 
both groups. 
Conclusion: Acute exercise elicits a pronounced and overall similar increase in expression of 
key transcription factors and activation of key upstream kinases involved in muscle metabolic 
adaptation to exercise in patients with T2D and weight-matched controls. 
We examined whether activation of key transcriptional regulators of skeletal muscle metabolism in 
response to exercise were attenuated in type 2 diabetes but found that these responses are 
preserved. 
Abbreviations 
AMPK - 5-AMP-activated protein kinase  
B2M - beta-2-microglobulin 
BMI – body mass index 
CaMKII - Ca2+/calmodulin-dependent kinases 
CREB - cAMP response element-binding protein 
FFA – Free fatty acids  
GDR - glucose disposal rates 
HGP – hepatic glucose production 
HKII - hexokinase II 
IPAQ - self-reported physical activity level 
NOGD - non-oxidative glucose disposal 
NR4A - nuclear hormone receptor 4A 
PPAR - peroxisome proliferator-activated receptor 
PPIA - peptidylprolyl isomerase A 
T2D – type 2 diabetes 
VO2max - maximal pulmonary oxygen uptake 
Introduction  
Insulin resistance plays a major role in the development of type 2 diabetes. In skeletal 
muscle, insulin resistance is characterized by impaired insulin signalling to glucose transport 
and glycogen synthesis, lipid accumulation and mitochondrial dysfunction (1-3). Exercise is 
an essential aspect of T2D prevention and treatment (4, 5). The beneficial metabolic effects 
of exercise include improved insulin sensitivity, improved maximal oxygen consumption and 
energy metabolism, increased skeletal muscle mass, and decreased adiposity (5, 6). In human 
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skeletal muscle, endurance exercise training increases the abundance of enzymes involved in 
glucose metabolism and insulin signalling as well as markers of mitochondrial biogenesis, 
mitochondrial content and function (6-9). 
Acute exercise and training affect a plethora of key signalling pathways involving 
enzymes such as 5-AMP-activated protein kinase (AMPK), Ca2+/calmodulin-dependent 
kinases (CaMK), Erk1/2, p38 MAPK, cAMP response element-binding protein (CREB) and 
protein kinase A (PKA) (6, 10-17). Activation of these signalling cascades in response to 
acute exercise induces an immediate but often transient transcriptional stress response of 
early-response genes such as the three members of the nuclear hormone receptor 4A (NR4A) 
subfamily, NR4A1, NR4A2 and NR4A3 (also known as Nur77, Nurr1 and Nor1, respectively) 
and ATF3, EGR1, JUNB, SIK1 as well as other key transcription factors involved in energy 
metabolism and mitochondrial biogenesis such as the peroxisome proliferator-activated 
receptor (PPARs) family members (6, 18-25). The induction of multiple down-stream target 
genes mediated by activation of these key transcriptional regulators is an essential aspect of 
skeletal muscle adaptation to exercise. Thus, emerging evidence implicates that NR4As are 
important regulators of major genes involved in glucose metabolism (e.g. SLC2A4, HKII, 
FBP2, PFKM, PYGM), and lipid and energy metabolism (e.g. PRKAG3, PDK4, CPT1B, 
LPIN1, PPARGC1A and PPARGC1B) (26-28).  
While the transcriptional signature elicited by exercise in healthy human skeletal muscle 
are well-studied (18-20, 23-25), the transcriptional response to exercise in insulin resistant 
conditions remains less well defined. However, some studies have reported an attenuated or 
absent increase in the gene expression, protein content or activity of AMPK, PGC-1alpha, 
HKII and other genes involved in the regulation of mitochondrial oxidative metabolism in 
response to acute exercise or exercise training in T2D, obesity and other high risk individuals 
(29-34). This suggests the existence of exercise resistance. The molecular mechanisms 
underlying an impaired response to exercise in insulin resistant individuals and patients with 
T2D, however, remain to be clarified. In particular, the effects of acute exercise on muscle 
expression of the NR4A family and their putative transcriptional target genes, as well as the 
activity of key up-stream kinases in patients with T2D are largely unknown. An altered 
exercise-mediated response within these pathways could contribute to the lack of beneficial 
metabolic effects of exercise in T2D.  
In this study, we hypothesised that the effect of acute exercise on key transcriptional 
regulators of metabolic adaptation is impaired in skeletal muscle of patients with T2D. The 
aim of the current study was to compare the effect of acute exercise on muscle expression of 
early stress response genes such as the NR4A family and down-stream target genes as well as 
activation of key up upstream kinases in patients with T2D and weight-matched, glucose 
tolerant individuals.  
Methods 
Participants 
Thirteen overweight/obese male patients with T2D group-wise matched according to BMI, 
age and self-reported physical activity with fourteen glucose tolerant male control individuals 
were included in the study. This study cohort is from a larger study of the effects of insulin 
and acute exercise (14, 15, 35, 36). The patients with T2D were GAD65-antibody negative, 
and with no signs of diabetic micro- or macrovascular complications. The control individuals 
had normal glucose tolerance, fasting glucose and no family history of diabetes. The patients 
with T2D were treated with metformin and sulfonylurea (n=4), diet alone (n=4) or by diet in 
combination with metformin (n=5). The study was approved by the Regional Scientific 
Ethical Committees for Southern Denmark and was conducted in accordance with the 
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Declaration of Helsinki. All the participants gave written informed consent before the study 
was commenced.  
Experimental Design 
At study entry, each participant underwent ECG, blood screening tests (including HbA1c and 
cholesterols) as well as an exercise test to determine maximal aerobic capacity (VO2max) and 
maximal workload (Wmax) capacity, as previously described (14, 15, 35, 36). All participants 
then underwent a euglycemic-hyperinsulinemic clamp at the baseline day and a 60 min acute 
exercise bout at the exercise day separated by 4–8 weeks. Seven days prior to each of the 
experimental days, all medications were withdrawn, and the participants were instructed to 
refrain from strenuous exercise for 48-h. On the baseline day, after an overnight fast, the 
participants underwent a 4-h euglycemic–hyperinsulinemic clamp (40 mU·m−2·min−1) using 
labeled glucose infusates and combined with indirect calorimetry to assess total glucose 
disposal rates (GDR), hepatic glucose production (HGP), rates of glucose and lipid oxidation 
and non-oxidative glucose disposal (NOGD) as previously described (14, 15, 35, 36).  Plasma 
glucose was allowed to decline to 5.5 mmol/l in the patients with T2D, before glucose 
infusion was initiated. GDR and HGP were calculated for the last 30 min of the basal and the 
insulin-stimulated states using Steele's non-steady-state equations adapted for labelled 
glucose infusates (14, 15, 35, 36). The volume of glucose distribution was assumed to be 200 
ml/kg and the pool fraction 0.65.  
On the exercise day, the participants returned after an overnight fast (14, 15, 35, 36). The 
participants were rested in bed for 30 min before the first skeletal muscle biopsy (basal) from 
the vastus lateralis muscle was obtained. Next, the participants performed a 60 min cycle 
ergometer exercise bout at 70% of VO2max. Immediately after the exercise cessation, the 
second skeletal muscle biopsy (exercise) from m. vastus lateralis of the same leg (new 
incision, but 4-5 cm proximal to the first biopsy site) was obtained. The third biopsy (3-h into 
recovery) was obtained from vastus lateralis of the previously spared leg. Tissue samples 
were obtained using a modified Bergström needle with suction under local anaesthesia (10 ml 
lidocaine 2%). Blood and connective was removed from skeletal muscle and immediately 
frozen in liquid nitrogen and stored at −80°C until further analysis.  
Muscle Processing, SDS-PAGE and Western Blotting Analyses  
Frozen muscle was freeze-dried and dissected free of visible blood, fat and connective tissue. 
Muscle lysate was prepared by homogenization of muscle tissue (1:80, weight:vol) in ice-
cold homogenizing buffer (pH = 7.4) containing 50 mM HEPES, 3 mM benzamidine, 20 mM 
β-glycerophosphate, 20 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 2 mM 
PMSF, 1 mM EDTA, 1 mM EGTA, 150 mM NaCl, 10% glycerol, 10 µg/ml leupeptin, 1 
µg/ml aprotinin, 10 mM sodium fluoride, and 1% Noidet P-40. The samples were 
homogenized in 2x1 min at 30 Hz using TissueLyser (Qiagen). Homogenates were rotated 
end-over-end for 1-h at 4◦C and centrifuged at 16.000 g at 4◦C for 20 min. Protein 
concentration in the muscle lysates was measured by the bicinchoninic acid method (Pierce 
Chemical Company, Rockford, IL, USA). Before separation by SDS-PAGE on self-cast Tris-
HCl (8-12 %) polyacrylamide gels (Bio-Rad, Herlev, Denmark), the muscle lysate proteins 
were boiled (96 ºC for 10 min) in Laemmli buffer. The proteins were transferred to a PVDF 
membrane (Immobilon transfer membrane, Millipore, Denmark) by semidry blotting. The 
membranes were blocked in Tris-buffered saline-Tween (TBST 10 nM Tris-base, 150 mM 
NaCl, and 0.05% Tween) containing milk (2-5%) or bovine serum albumin (BSA - 5%) and 
incubated overnight at 4°C with primary antibodies, and next day incubated with a secondary 
HRP-conjugated antibody. Protein bands were detected with enhanced chemical 
luminescence (Merck Millipore, Denmark) and visualized using ChemiDoc XRS+ system 
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(Bio–Rad Laboratories, Herlev, Denmark). The protein bands were quantified by using Image 
Lab version 5.2.1 (Bio–Rad Laboratories, Herlev, Denmark). 
Antibodies   
The following antibodies were used: p38 MAPK protein (1:500 in 5% BSA), Cell Signaling 
Technology (#9212), MA, USA; p38 MAPK Thr180/Tyr182 phosphorylation (1:500 in 5 % 
milk), Cell Signaling Technology (#9211), MA, USA; Erk1/2 protein: p44/p42 MAPK 
(Erk1/2 – 1:1000 in 3% milk), Cell Signaling Technology (#4695), MA, USA; Erk1/2 
Thr202/Tyr204 phosphorylation: Phospho-p44/42 MAPK (Erk1/2 - 1:1000 in 3% milk), Cell 
Signaling Technology (#9101), MA, USA, Ca2+/calmodulin-dependent protein kinase II 
(CaMKII protein – 1:5000 in 5 % BSA), BD Biosciences (#611293), San Jose, CA; CaMKII 
Thr286 phosphorylation (1:500 in 5 % BSA), Cell Signaling Technology (#12716), MA, USA; 
Hexokinase (HKII – 1:500 in 2 % milk), Cell Signaling Technology (#2867), MA, USA; 
Glucose transporter type 4 (GLUT4 – 1:1000 in 2 % milk ), Thermo Fisher Scientific (#PA1-
1065), CREB phosphorylation Ser133 (1:1000 in 3% milk), Cell Signaling Technology 
(#9198), MA, USA; CREB (1:500 in 3% milk), Cell Signaling Technology (#9197), MA, 
USA.  
RNA Extraction, Reverse Transcription and Quantitative Real-time PCR  
Total RNA was isolated from the skeletal muscle tissue as previously described (37). RNA 
was reverse transcribed to cDNA using the high capacity cDNA reverse transcription kit 
(Life Technologies/Applied Biosystems, Foster City, CA, USA). Quantitative real-time PCR 
was performed using on a 7900HT Fast Real-Time PCR System (Life Technologies/Applied 
Biosystems, Foster City, CA, USA) using TaqMan Custom Arrays (Life 
Technologies/Applied Biosystems, Foster City, CA, USA) according to the manufacturer´s 
instructions. Primers used for quantitative real-time PCR analysis are listed in Supplemental 
Table 2. All samples were run in triplicates. Gene expression data was analysed using qBase+ 
Biogazelle software (Zwijnaarde, Belgium) (38, 39) and normalised to the geometric mean of 
two reference genes, peptidylprolyl isomerase A (PPIA) and beta-2-Microglobulin (B2M).  
Statistical Analyses 
All data were analysed using SigmaPlot 13.0 software (Systat Software, San Jose, CA, USA). 
Variables with a skewed distribution were logarithmically transformed before statistical 
analysis across cohorts or across exercise time points. Two-way ANOVA with repeated 
measures, followed by Student-Newman-Keul post hoc analysis, was performed when 
comparisons were made among all groups. Correlation analyses were performed using the 
Spearman rank correlation coefficient. Statistical significance was accepted at P<0.05. All 
data are given as means ± SEM. The protein and mRNA data are presented as fold-change to 
the controls in the basal state. 
Results 
Clinical and metabolic characteristics 
As reported before (14, 15, 35, 36), at study entry patients with T2D were characterized by 
hyperglycemia, but similar body composition, plasma triglyceride levels, VO2max and self-
reported physical activity (IPAQ-score) compared with age and weight-matched, glucose 
tolerant individuals (Table 1). At the baseline day, patients with T2D had reduced insulin-
stimulated GDR, glucose oxidation and NOGD and impaired insulin-mediated suppression of 
lipid oxidation and plasma FFA, whereas insulin suppression of HGP was intact as shown in 
Supplemental Material (40) 
Effects of exercise on NR4As and other early stress response genes in skeletal muscle  
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In both groups, we observed that the expression of NR4A1 (~4-fold), NR4A2 (~36-fold) and 
NR4A3 (~15-fold) were robustly and similarly increased (all P<0.001) immediately after 
exercise compared with basal (Fig. 1A-C). The mRNA levels of NR4A3 (~75-fold) and 
NR4A1 (~8-fold) were even further increased 3-h into recovery in both groups (all P>0.001) 
compared with basal and immediately after exercise, whereas the mRNA levels of NR4A2 
(P<0.001) returned toward basal levels 3-h into recovery. Importantly, no differences in 
mRNA levels or exercise-induced changes in the expression of these genes were observed 
between groups. Examination of other early stress response genes showed that the muscle 
transcript levels of ATF3 (~5-fold, P<0.001), EGR1 (~12-fold, P<0.001), JUNB (~10-fold 
P<0.001), and SIK1 (~6-fold, P<0.001) (Fig. 1D-G) were robustly and equally increased 
immediately after exercise in both groups compared with basal. Only ATF3 mRNA levels 
returned (P<0.001) towards basal levels, whereas the mRNA levels of EGR1 (~5-fold, 
P<0.001), JUNB (~2.5-fold, P<0.001), and SIK1 (~4-fold, P<0.001) remained upregulated 3-
h into recovery in both groups (Fig. 1D-G). No differences in the muscle transcript levels or 
exercise-induced changes in these transcripts were detected between the groups.  
Effects of exercise on key upstream kinases regulating NR4As 
There is evidence that p38 MAPK, Erk1/2, CaMKII and CREB are upstream regulators of 
NR4A1 and NR4A3 in response to exercise (26, 41). Thus, we decided to examine the effect 
of acute exercise on the protein abundance and phosphorylation of these kinases. At basal, 
there were no differences in the protein content or phosphorylation of p38 MAPK, Erk1/2, 
CaMKII and CREB between the two groups (Fig. 2A-G) and Suppl. Fig. 1. [40]). 
Phosphorylation of p38 MAPK increased (~2-fold) immediately after exercise (P<0.001) and 
remained elevated 3-h into recovery (P<0.001) in both groups compared with basal with no 
differences between the groups. No changes in the protein content of p38 MAPK in response 
to exercise or recovery or differences between the groups were seen (Suppl. Fig. 2A [40]). 
Phosphorylation of Erk1 and Erk2 was increased (~1.5 to 4-fold; P<0.001) immediately after 
exercise and remained elevated (~1.5 and ~6-fold; P<0.05) compared with basal in both 
groups (Fig. 2B and C). The protein content of Erk1, but not Erk2, was slightly increased 3-h 
into recovery (P=0.044) compared with immediately after exercise. However, the effect of 
exercise on Erk1 phosphorylation was intact even if adjusted for protein content (data not 
shown). The phosphorylation of the CaMKII isoforms βM and γ/δ increased 3-h into recovery 
compared with basal (P<0.05) and immediately after exercise (P<0.001) (Fig. 2D and E). No 
changes in protein content of CaMKII were observed in response to exercise or 3-h into 
recovery (Suppl. Fig. 2D and E [40]). We observed that acute exercise increased the CREB 
phosphorylation (~1.3-fold; P=0.036) in both groups and remained elevated 3-h into recovery 
(~1.5-fold; P<0.001) in both groups compared with basal (Fig. 2F). However, the protein 
content of CREB was also slightly increased 3-h into recovery compared with basal 
(P<0.001) (Suppl. Fig. 2F [40]). Thus, when adjusted for changes in protein content, we 
could no longer demonstrate increased CREB phosphorylation 3-h into recovery (data not 
shown).  
Effects of exercise on known NR4A1 and NR4A3 target genes 
We next examined the effect of exercise on muscle expression of selected proposed 
downstream target genes of NR4A1 and NR4A3 (FBP2, SLC2A4, LPIN1, PDK4, PFKM, 
CPT1B, PYGM, HKII, and PRKAG3) and other important regulators of glucose metabolism 
(GAPDH, HDAC5, and SIRT1) (26). The muscle expression of HKII increased (~2-fold; 
P=0.002) 3-h into recovery in both groups compared with basal (Fig. 3A). Muscle expression 
of HKII also tended to be increased immediately after exercise compared with basal 
(P=0.063, main effect) (Fig. 3A). This was mainly explained by a 1.8-fold increase in 
controls compared with a 1.1-fold increase in the diabetic group. However, there was no 
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difference in the exercise-induced changes in HKII expression between the groups. The 
expression of HKII was markedly lower in patients with T2D compared with the weight-
matched individuals throughout the exercise test (P=0.004, main effect) (Fig. 3A). HKII 
protein abundance was decreased in the diabetic group compared with the weight-matched 
individuals throughout the study (P=0.02, main effect) but no effect of exercise was detected 
(Fig. 3B). The mRNA levels of SLC2A4 (encoding GLUT4) increased immediately after 
exercise (P=0.021), but then decreased 3-h into recovery compared with basal in both groups 
(Fig. 3C). Interestingly, the SLC2A4 expression was lower in the patients with T2D (P=0.044, 
main effect) compared with the weight-matched individuals throughout the exercise study 
(Fig. 3C). We observed no difference in the exercise-induced changes in SLC2A4 expression 
between groups. GLUT4 protein content did not change in response to acute exercise or 3-h 
into recovery and no difference in the GLUT4 protein content was observed between the two 
groups (Fig. 3D). In both groups, GAPDH mRNA levels decreased 3-h into recovery 
(P=0.024) compared to basal (Fig. 3H). The PDK4 mRNA levels increased (P<0.001) 
immediately after exercise and remained elevated 3-h into recovery (P<0.001) (Fig. 3J), 
while the expression of PYGM involved in muscle glycogenolysis, decreased 3-h into 
recovery compared with basal (P=0.039) and post exercise (P=0.006) with no difference 
between the groups (Fig. 3L). There were no significant effect of exercise on the expression 
of FBP2, PFKM, CPT1B, LPN1, HDAC5, SIRT1 or PRKAG3 (encoding the regulatory γ3-
subunit of AMPK) were observed (Fig. 3 and Suppl. Fig. 2 [40]).  
Effects of exercise on PPARGC1B and PPARs  
Downstream targets of NR4A3 include PPARGC1A and PPARGC1B (26), which are known 
to co-activate PPARs involved in fatty acid metabolism, energy homeostasis and 
mitochondrial biogenesis such as PPARA, PPARD and PPARG (42). In this study cohort, we 
have previously reported that muscle expression of PPARGC1A increased 3-h into recovery 
(~6.5-fold) with no difference between the two groups (15). However, here we observed that 
the expression of the analogous PPARGC1B did not change significantly in response to 
exercise or recovery (Fig. 4A). PPARA mRNA levels decreased (P=0.004) 3-h into recovery 
with no difference between the groups (Fig. 4B). The muscle transcript levels of PPARG 
increased ~1.3-fold (P=0.026) immediately after exercise in both groups compared with basal 
with no difference between the groups (Fig. 4C). The PPARD mRNA levels were not 
significantly altered in response to either exercise or 3-h into recovery (Fig. 4D). The 
respiratory complex III gene UQCRB (Ubiquinol-Cytochrome C Reductase Binding Protein) 
was reported to be one of the PPARGC1A-responsive genes, which were downregulated in 
skeletal muscle in patients with T2D and correlated with total-body aerobic capacity (43). 
Here, we show that the muscle expression of UQCRB did not change in response to exercise 
or 3-h into recovery (Fig. 4E). However, UQCRB gene expression was lower in patients with 
T2D compared with the control individuals (P = 0.048, main effect) (Fig. 4E). Importantly, 
we observed no differences in the exercise-induced changes in the expression of these genes 
between groups.   
Correlation Analyses  
Correlation analyses was performed to explore the potential relationship between baseline 
metabolic characteristics (measured on the baseline day) and the magnitude of the exercise-
mediated upregulation (∆-values) of key transcriptional regulators of metabolic adaptation 
(NR4A1, NR4A2, NR4A3, ATF3, EGR1, JUNB, SIK1, HKII, SLC2A4, PDK4 and PPARG) in 
the total cohort (n=27). BMI correlated inversely with the exercise-mediated upregulation of 
NR4A1, NR4A2 and JUNB (r=-0.41 to r=-0.55, P<0.04), and tended to correlate inversely 
with the upregulation of NR4A3 and ATF3 (P≤0.10). Although both fat free mass and fat 
mass showed similar inverse relationships with the upregulation of these early response genes 
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(not shown), percent body fat also correlated inversely with the exercise-mediated increase in 
NR4A2, ATF3 and JUNB (r=-0.43 to r=-0.45, P<0.03) and tended to correlate inversely with 
upregulation of NR4A1 (r=-0.37, P=0.061). indicating a role for adiposity per se. Fasting 
insulin correlated inversely with the increase in NR4A2 expression (r=-0.41; P=0.025), but 
neither VO2max, fasting plasma glucose, plasma FFA nor HbA1c correlated with the 
upregulation of any of these genes. Importantly, the exercise-mediated upregulation of these 
genes did not show any correlation with insulin action on insulin sensitivity measured as 
insulin-stimulated GDR, glucose oxidation and glucose storage or the ability of insulin to 
suppress HGP or circulating levels of FFA. 
Discussion  
Regular exercise causes numerous beneficial metabolic effects such as enhanced insulin 
sensitivity, improved VO2max and increased markers of mitochondrial biogenesis (5, 6). The 
beneficial metabolic effects of exercise are elicited by alterations in the transcriptome and the 
proteome (6, 17, 18, 22, 25). Although, exercise causes beneficial metabolic effects in most 
individuals, some studies of patients with T2D and prediabetes have reported an attenuated or 
absent improvement in insulin sensitivity, VO2max or muscle PPARGC1A, HKII and AMPK 
signalling in response to exercise (29-34), suggesting the existence of exercise resistance. In 
the present study, we investigated, whether the effects of a single bout of exercise on the gene 
expression and protein content and activity of several key regulators of metabolic adaptation 
in human skeletal muscle were attenuated in patients with T2D.  
Acute exercise increases the expression of various early stress response genes in human 
skeletal muscle (18, 22, 24, 25). Here, we show that the expression of the three NR4A family 
members and ATF3, EGR1, JUNB, SIK1 were robustly and equally increased in patients with 
T2D and glucose-tolerant weight-matched individuals. Our data support previous studies of 
lean young and middle-aged healthy men showing exercise-induced expression of NR4As 
(18, 25). However, we are the first to show that the robust exercise-mediated induction of 
these major early stress response genes is preserved in muscle of patients with T2D. 
Compared to a recent almost similar study (22), we observed a much more robust exercise-
induced increase (~4-15 fold) in muscle expression of NR4A3 and EGR1, and specifically 
NR4A3 was further markedly increased (~75-fold) 3-h into recovery in both patients with 
T2D and weight-matched controls. The higher and more sustained exercise-mediated 
induction of NR4A3 could be explained by the use of a higher exercise intensity (70% vs. 
50% of VO2max) in our exercise protocol. A reduced NR4A1 mRNA expression in skeletal 
muscle of obese men compared with lean men has previously been reported (44). Although, 
we are unable to exclude an effect of obesity on NR4As in our study, we found no differences 
in the muscle expression of any of the NR4As between the groups despite a significant 
reduction in insulin sensitivity in patients with T2D. Accordingly, we found no correlation 
between exercise-induced upregulation of NR4As and glycemic control or insulin action on 
GDR, HGP and lipolysis supporting an intact response in insulin resistant patients with T2D. 
Interestingly, the correlation analysis indicated that adiposity per se rather than insulin 
resistance may negatively influence the exercise-mediated increase in expression of NR4As. 
However, the lack of correlation to insulin action does not prove that exercise-mediated 
upregulation of NR4As and other early-response genes, are independent of insulin resistance, 
and therefore further studies of this are warranted.  
To further characterize the pronounced exercise-mediated induction of muscle NR4As in 
both groups, we examined key upstream kinases (p38 MAPK, Erk1/2 MAPK, CaMKII and 
CREB) and a selected panel of downstream targets of NR4A1 and NR4A3 as well as other 
key transcription factors involved in glucose and lipid metabolism and mitochondrial 
biogenesis (26, 41). All the examined key upstream kinases were equally induced by exercise 
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in both groups. Our findings are consistent with studies in healthy individuals
 
[10, 11] and in 
patients with T2D showing an intact p38 MAPK phosphorylation in response to acute 
exercise in skeletal muscle [12]. The exercise-induced phosphorylation of Erk1/2 has not 
been investigated in muscle of patients with T2D or obese individuals before but showed the 
same response to exercise as p38 MAPK phosphorylation in both groups. Thus, in contrast to 
the effect of acute one-legged exercise on Erk1/2 phosphorylation in young healthy 
individuals (10), phosphorylation of Erk1/2 in muscle remained elevated 3-h into recovery in 
obesity and T2D. We also detected an effect of exercise 3-h into recovery on the 
phosphorylation of CaMKII. These findings are in line with studies, which have reported that 
endurance exercise training increases the activity and CaMKII phosphorylation in human 
skeletal muscle (11, 13). Phosphorylation of CREB has been shown to be increased in 
response to stress, elevated Ca2+ concentrations and cAMP, and many other stimuli (45). 
Some studies have reported that exercise increases CREB phosphorylation in human skeletal 
muscle (11, 16), while one study showed that CREB phosphorylation was only increased in 
the non-exercised leg (10). We observed increased phosphorylation of CREB both 
immediately after exercise and 3-h into recovery in both groups, but also a small increase in 
protein content of CREB 3-h into recovery, which may have contributed to the concomitant 
increase in CREB phosphorylation. 
AICAR stimulation of AMPK causes increased expression of NR4A1 and NR4A3 in rat 
muscles (46), suggesting a role for AMPK in the transcriptional regulation of NR4As in 
response to exercise. Moreover, there is evidence that induction of the NR4A family in 
skeletal muscle involves enhanced β-adrenergic signaling and increased calcium influx (47). 
These responses appear to be mediated by cAMP, PKA, MAPKs, CREB and CaMKII (26, 
41). However, to what extent AMPK and the other examined key upstream kinases 
regulators, p38 MAPK, Erk1/2 MAPK, CaMKII and CREB are directly involved in the 
regulation of NR4A1 and NR4A3 in human skeletal muscle remains to be fully clarified. 
Nevertheless, our results, together with a previous report of intact exercise-mediated 
activation of AMPK in patients with T2D in the same study (14, 15), demonstrate that the 
observed intact induction of the NR4A family in response to acute exercise are consistent 
with an intact activation of these up-stream kinases in muscle of patients with T2D.  
The examined downstream target genes of NR4A1 and NR4A3 showed a similar 
response to acute exercise in patients with T2D and weight-matched controls. Despite no 
significant differences in the exercise-induced muscle expression of HKII and SLC2A4 
between the groups, we observed reduced muscle expression of HKII and SLC2A4 (encoding 
GLUT4) in patients with T2D throughout the exercise study. Accordingly, the protein 
abundance of HKII, but not GLUT4, was reduced in muscle of patients with T2D. These 
findings are in agreement with previous reports of decreased gene expression, protein content 
and activity of HKII in skeletal muscle of patients with T2D (48). However, exercise training 
has been shown to increase the HKII and GLUT protein abundance (9, 49, 50) also in patients 
with T2D, indicating a pronounced positive effect of long-term exercise training on HKII and 
GLUT4 protein contents. While most previous studies have reported normal mRNA and 
protein content of GLUT4 in skeletal muscle of patients with T2D (12, 51-54), lower mRNA 
levels despite normal protein content of GLUT4 in muscle was also observed in another study 
of patients with T2D treated with diet or oral antidiabetic drugs (55). These discrepancies are 
most likely explained by differences in sample size, matching criteria such as weight, daily 
physical activity levels and duration and treatment of diabetes. Some studies have suggested 
that the proposed upstream regulators of NR4As, such as CaMKII, p38 MAPK, Erk1/2, 
CREB and AMPK may also be involved in the transcriptional regulation of SLC2A4 (6, 56). 
However, the finding of an intact and equal regulation of the above-mentioned kinases 
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including AMPK (14, 15), suggests that other factors must be responsible for the reduced 
muscle expression of HKII and SLC2A4 observed in patients with T2D in our study.  
PPARGC1A and PPARGC1B are putative downstream targets of NR4A3 (26) and co-
activate members of the PPAR family, which are all important regulators of energy 
metabolism (42). We and other groups have previously reported an exercise-mediated 
induction of PPARGC1A 3-h into recovery in muscle of patients with T2D and matched 
controls (12, 15, 22). We, therefore, expected a similar exercise-induced expression of 
PPARD, PPARG and PPARA, at least in the recovery period. However, no effect of exercise 
was observed on PPARGC1B and PPARD expression, which is consistent with other studies 
of patients with T2D and weight-matched controls (57). In another study, acute exercise was 
shown to increase muscle PPARD mRNA levels in healthy individuals 4-h into recovery (18), 
indicating that the transcriptional response might be detected later than 3-h. Our findings of 
exercise-induced changes in PPARG and PPARA transcript levels are in line with some 
previous studies of the effect of a single bout of exercise in human skeletal muscle (18, 23). 
However, a recent study showed that muscle PPARA expression was reduced in the resting, 
basal state, and did not alter in response to exercise in patients with T2D compared with 
weight-matched individuals (57). The intact exercise-induced expression of NR4As and their 
putative downstream target, PPARGC1A, suggests that the exercise-induced mitochondrial 
biogenesis known to be orchestrated by PGC-1alpha is preserved in muscle of patients with 
T2D. However, in our study we did not measure activation of PGC-1alpha, which may be 
more important than increased expression of PGC-1alpha for the immediate effects of 
exercise on mitochondrial biogenesis (58). Moreover, we did not measure mitochondrial 
biogenesis at a time point after the observed increase in PPARGC1A expression 3h into 
recovery. Nevertheless, a previous study from our group demonstrated a robust and intact 
increase in markers of mitochondrial content and mitochondrial respiration in muscle of 
patients with T2D compared to weight-matched control after 10 weeks endurance exercise 
training (7). Moreover, the intact ability to induce muscle PPARGC1A in response to acute 
exercise suggests that other factors explain the reduced expression of UQCRB we observed in 
skeletal muscle of patients with T2D. 
 The limitations of our study include a small sample size and the lack of a lean, healthy 
group to exclude the possibility that obesity itself causes exercise resistance. Another 
limitation is lack of women in our cohort in order to rule out a gender-specific-effect of 
exercise on the investigated key regulators. Moreover, we cannot exclude that an altered 
response to an acute bout of exercise in patients with T2D may be seen later than 3-h into 
recovery or in response to other types or intensities of exercise. Importantly, we recruited 
patients with T2D with a short duration of diabetes, a good glycaemic control and absence of 
diabetic complications. This means that we cannot extrapolate our findings to all cases with 
T2D. However, the major strength of our study is the study design and that the participants 
were well-matched according to age, BMI, VO2max and daily physical activity level.  
The major findings from the present study are that the activation of key transcriptional 
regulators of muscle metabolism in response to acute exercise was generally preserved in 
patients with T2D compared with weight-matched individuals. Specifically, we report a 
robust and intact exercise induction of major transcriptional factors such as NR4As as well as 
activation of key upstream kinases involved in the metabolic adaptation to exercise in skeletal 
muscle of patient with T2D. While future studies should investigate the biological role(s) of 
the members of NR4A related to muscle metabolism and signalling pathways, our data do not 
support the existence of exercise resistance within the examined key transcriptional 
regulators of muscle metabolism in T2D, and therefore do not argue against a beneficial 
effect of exercise also in patients with T2D.  
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Figure 1. The effect of exercise on early stress response genes. mRNA expression of (A) 
NR4A1, (B) NR4A2, (C) NR4A3 and (D) ATF3 (E) EGR1 (F) JUNB and (G) SIK1 in human 
skeletal muscle of patients with T2D (white bars) and healthy control individuals (black bars) 
before (basal) and immediately after (Exercise) 60 min of exercise at ~70% VO2max and after 
3-h into recovery (3-h Recovery). Values are means ± SEM (n=13 in each group). ***P<0.001 
compared with basal (main effect), §§§P<0.001 compared with exercise (main effect).  
Figure 2. Phosphorylation of putative upstream regulators of NR4A1 and NR4A3. (A) p-p38 
MAPK Thr180/Tyr182, (B) p-Erk1 MAPK Thr202/Tyr204, (C) p-Erk2 MAPK Thr185/Tyr187, (D) 
p-CaMKII γ/δ Thr286, (E) p-CaMKII βM, and (F) p-CREB Ser133 in skeletal muscle of patients 
with T2D (white bars) and healthy control individuals (black bars) before (basal) and 
immediately after (Exercise) 60 min of exercise at ~70% VO2max and after 3-h into recovery 
(3-h Recovery). (G) Representative immunoblots. Values are means ± SEM (n=14 controls 
and n=13 T2D). *P<0.05, ***P<0.001 compared with basal (main effect), §P<0.05 and 
§§§P<0.001 compared with exercise (main effect), (§)P<0.1 compared with exercise (main 
effect). 
Figure 3. The effect of exercise on downstream targets of NR4A1 and NR4A3 and other key 
regulators of metabolic adaptation to exercise. mRNA expression and protein abundance of 
putative downstream targets of NR4A1, NR4A3 and other key regulators: (A) HKII, (B) HKII 
protein, (C) SLC2A4, (D) GLUT4 protein (encoded by SLAC2A4), (E) Representative 
immunoblots, (F) FBP2, (G) PFKM, (H) GAPDH, (I) CPT1B, (J) PDK4, (K) LPIN1, (L) 
PYGM and (M) PRKAG3 in skeletal muscle of patients with T2D (white bars) and healthy 
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control individuals (black bars) before (basal) and immediately after (Exercise) 60 min of 
exercise at ~70% VO2max and after 3-h into recovery (3-h Recovery). Values are means SEM 
(n=14 controls and n=13 T2D). *P<0.05, ***P<0.001 compared with basal (main effect), 
§P<0.05, §§§P<0.001 compared with exercise (main effect), (*)P<0.1 compared with basal 
(main effect), #P<0.05 vs. controls (main-effect).  
Figure 4. The effect of exercise on PPARs. Transcript levels of PPARs and UQCRB. (A) 
PPARGC1B, (B) PPARA, (C) PPARG, (D) PPARD, and (E) UQCRB in skeletal muscle of 
patients with T2D (white bars) and healthy control individuals (black bars) before (basal) and 
immediately after (Exercise) 60 min of exercise at ~70% VO2max and after 3-h into recovery 
(3-h Recovery). Values are means ± SEM (n=13 in each group). *P<0.05 compared with 
basal (main effect), §P<0.05 compared with exercise (main effect), #P<0.05 vs. controls (main 
effect).  
Table 1. Clinical and metabolic characteristics at study entry. 
 Controls Type 2 diabetics 
n 14 13 
Age (years) 54.7 ± 2.3 55.4 ± 2.0 
BMI (kg/m2) 29.0 ± 0.9  29.7 ± 1.0  
Fat free mass (kg) 69.1 ± 2.4 68.3 ± 2.0 
Fat mass (kg) 24.5 ± 1.9 28.1 ± 2.4  
Percent body fat (%) 25.7 ± 1.1 28.6 ± 1.4 
Fasting plasma glucose (mmol/l) 5.6 ± 0.1  10.0 ± 0.7 ** 
HbA1c (%) 5.5 ± 0.1 7.0 ± 0.2 ** 
Plasma cholesterol (mmol/l) 5.7 ± 0.3 4.4 ± 0.4 * 
Plasma LDL-cholesterol (mmol/l) 3.8 ± 0.3 2.0 ± 0.2 ** 
Plasma HDL-cholesterol (mmol/l) 1.3 ± 0.1 1.2 ± 0.1  
Plasma triglycerides (mmol/l) 1.5 ± 0.2 3.2 ± 1.5  
IPAQ score 5248 ± 952 5558 ± 943 
VO2max (l/min) 3.50 ± 0.2 3.2 ± 0.2 
Wmax (W) 236 ± 12 196 ± 20 
Diabetes duration (years) - 3.5 ± 1.2 
Data are mean ± SEM. *P<0.05 and **P<0.001 compared with control subjects. IPAQ score, metabolic 
equivalent minutes according to International Physical Activity Questionaire; VO2max, maximal oxygen uptake 
capacity; Wmax, maximal workload capacity.  
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